Physician profile
Alexandra Divinsky
NPI 1477644185
$11,243.16
in general payments reported to CMS, 2019-2025
49 companies · $3,433 in 2025
The $3,433 reported for 2025 was more than what 78% of Neuroscience (Registered Nurse) providers received nationally (typical 2025 total: $185).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,560 · 2022: $1,922 · 2023: $2,061 · 2024: $2,268 · 2025: $3,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,676 · Education: $85.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,676.41 |
| Education | $85.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,746.51 | 2021-2025 | |
| Sk Life Science, INC. | $858.86 | 2021-2025 | |
| Lundbeck LLC | $563.08 | 2021-2025 | Vyepti, Rexulti |
| Merz Pharmaceuticals, LLC | $520.13 | 2021-2025 | Xeomin |
| Argenx US, INC. | $457.10 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $440.25 | 2021-2025 | Briviact |
| Lilly USA, LLC | $426.39 | 2021-2025 | Emgality, Amyvid, Kisunla |
| Takeda Pharmaceuticals U.S.A., INC. | $381.50 | 2021-2025 | Hyqvia, Gammagard |
| Biogen, INC. | $362.84 | 2021-2023 | Vumerity, Tysabri |
| Neurelis, INC. | $351.64 | 2021-2025 | Valtoco |
| Amneal Pharmaceuticals LLC | $340.71 | 2021-2025 | Crexont, Rytary |
| Axsome Therapeutics, INC. | $331.81 | 2025 | Symbravo |
| Acadia Pharmaceuticals INC | $308.78 | 2023-2025 | Nuplazid, Daybue |
| Csl Behring | $272.43 | 2021-2025 | Hizentra |
| Amgen INC. | $242.17 | 2024-2025 | Uplizna |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Divinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.